Current applications of the microbiome engineering and its future: A brief review

Zahra Malayejerdi, Omid Pouresmaeil


In the human body there are many microorganisms with a variable genetic content. These microorganisms play an important role in the metabolism, homeostasis, immune system and generally human health. Over the millions of years, different microorganisms adapted to each other, and different environmental communities formed on Earth. Microbial communities, known as microbiome, could exist in living or non-living environments, such as human body and plants, as well as in soil, oceans, and air. The main purpose of microbiome engineering is mostly human microbiome and is now used in the treatment of diseases such as Clostridium difficile infection, inflammatory bowel disease, obesity, etc. The research data in this thesis were collected from the main medical article sources including Web of science, Google scholar, PubMed and Scopus. Articles on microbiome which published during 2010-2019 were reviewed. The widespread impacts of the microbiome on the ecosystems and the increased attention to microbiome recognition are factors contributing to the creation of microbiome engineering science, and recent advances in genome sequencing and metagenomic science have made microbiome analysis apart from cultivation process. Microbiome engineering has advantages and disadvantages. So, according to the positive aspects and efforts to increase applications, this science could lead to advances in microbial engineering, and have positive effects on human health. Although microbiome engineering is a new field, there has been lots of progressions in recent years that can be an important strategy for improving human health by microbial manipulation leading to the changing of microbial population.


Microbiome; Human Gut Microbiome; Microbiome engineering; Microbiota


Kim BS, Jeon YS, Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr. 2013; 16(2):71-9.

Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016; 8(1):51.

Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012; 12(5):611-22.

Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012; 70 Suppl 1(Suppl 1):S38-44.

Prescott SL. History of medicine: Origin of the term microbiome and why it matters. Hum Microbiome J. 2017; 4:24-5.

Foo JL, Ling H, Lee YS, Chang MW. Microbiome engineering: Current applications and its future. Biotechnol J. 2017; 12(3).

Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015; 3(1):31.

Phillips CD, Phelan G, Dowd SE, McDonough MM, Ferguson AW, Delton Hanson J, et al. Microbiome analysis among bats describes influences of host phylogeny, life history, physiology and geography. Mol Ecol. 2012; 21(11):2617-27.

Jung Lee W, Lattimer LD, Stephen S, Borum ML, Doman DB. Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y). 2015; 11(1):24-32.

Culligan EP, Sleator RD. Advances in the Microbiome: Applications to Clostridium difficile Infection. J Clin Med. 2016; 5(9).

Hansen JJ, Sartor RB. Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches. Curr Treat Options Gastroenterol. 2015; 13(1):105-20.

Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham L-D, et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019; 25(7):1104-9.

Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36(5):305-12.

Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014; 6(265):265sr6.

O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015; 277:32-48.

Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015; 63:1-9.

Babakhani S, Hosseini F. Gut Microbiota: An Effective Factor in the Human Brain and Behavior. Shefaye Khatam. 2019; 7(1):106-118.

Hwang IY, Koh E, Kim HR, Yew WS, Chang MW. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria. Drug Resist Updat. 2016; 27:59-71.



Copyright (c) 2020 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.